Skip to content
OpenCapital
Get started

Xeris Biopharma Holdings, Inc. XERS EBITDA

EBITDA at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$3.55M+553%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$161M-20.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$52.51M+1,514%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$59.81M+21.8%
Eli Lilly logo
Eli LillyLLY
——
Corcept Therapeutics logo
Corcept TherapeuticsCORT
——

Other financials

Income statement

See full
Revenue$83.1M+38.3%
Gross profit$72.6M+41.2%
Operating income$7.9M+356%
Net income$2.2M+124%
EPS (diluted)$0.01+117%

Balance sheet

See full
Cash & equivalents$111.8M+91.2%
Total debt$258.6M-3.8%
Total equity$13.0M+137%
Total assets$392.0M+24.3%

Cash flow

See full
Operating cash flow$9.9M+198%
CapEx$131.0K—
Free cash flow-$29.1M—

Valuation

See full
Market cap$1.28B+76.9%
Enterprise value$1.42B+52.7%
P/E106.4×—
P/S4.1×+0.8×

Profitability

See full
Gross margin85.9%+3.7pp
Operating margin11.4%+7.7pp
Net margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-209.8%—
Debt / equity19.9×—
Current ratio2.1×+0.4×

Where this comes from

Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.

$7.9Mebit+
$337.0KDepreciation Depletion & Amortization
=$8.25M

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s EBITDA?
Xeris Biopharma Holdings, Inc. (XERS) reported EBITDA of $8.25M in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s EBITDA changed year-over-year?
Xeris Biopharma Holdings, Inc.'s EBITDA increased by 397.4% year-over-year, from -$2.78M to $8.25M.
What is the long-term trend for Xeris Biopharma Holdings, Inc.'s EBITDA?
Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s EBITDA has grown at a -30.7% compound annual growth rate (CAGR), from -$113.83M to $26.21M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.